Table 2. Poisson Regression – Likelihood of Late Treatment.
Late Treatment | IRR (CI 95%) | p value |
---|---|---|
Age | ||
< 40 yo | 1.07 (1.01–1.13) | 0.014 |
40–49 | 0.86 (0.83–0.89) | <0.001 |
50–59 | 0.87 (0.84–0.90) | <0.001 |
60–69 | 0.92 (0.90–0.94) | <0.001 |
> 70 yo | Reference | |
Race/Ethnicity | ||
Non-Hispanic White | Reference | |
Non-Hispanic Black | 1.35 (1.28–1.42) | <0.001 |
Hispanic | 1.31 (1.20–1.43) | <0.001 |
Asian | 1.15 (1.01–1.30) | 0.029 |
Other/Unknown | 1.05 (0.97–1.15) | 0.229 |
Insurance Status | ||
Private Insurance | Reference | |
Medicaid/Uninsured | 1.43 (1.37–1.50) | <0.001 |
Income | ||
Lowest quartile | 0.95 (0.87–1.05) | 0.347 |
Second quartile | 0.93 (0.86–1.01) | 0.067 |
Third quartile | 0.95 (0.89–1.0) | 0.046 |
Fourth quartile | Reference | |
Unknown | 0.592 | |
Education | ||
Lowest quartile | 1.28 (1.17–1.40) | <0.001 |
Second quartile | 1.21(1.14–1.28) | <0.001 |
Third quartile | 1.14 (1.09–1.19) | <0.001 |
Fourth quartile | Reference | |
Unknown | 0.75 (0.20–2.87) | 0.677 |
CoMorbidity | ||
Charlson-Deyo Score 0 | Reference | |
Charlson-Deyo Score 1 | 1.14 (1.10–1.18) | <0.001 |
Charlson-Deyo Score 2 | 1.36 (1.29–1.42) | <0.001 |
AJCC Stage | ||
Stage 0 | 1.10 (0.90–1.36) | 0.357 |
Stage 1 | 1.21(1.04–1.41) | 0.012 |
Stage 2 | 1.36 (1.16–1.59) | <0.001 |
Stage 3 | 1.16 (1.00–1.34) | 0.045 |
Grade | ||
1 | Reference | |
2 | 0.93 (0.90–0.96) | <0.001 |
3 | 0.82 (1.01–1.11) | <0.001 |
Unknown | 1.00 (0.94–1.06) | 0.914 |
Nodes | ||
Negative | Reference | |
Positive | 1.06 (1.01–1.11) | 0.020 |
Not done | 1.14 (1.10–1.19) | <0.001 |
Unknown | 1.04 (0.83–1.29) | 0.754 |
Year of Treatment | ||
2003 | Reference | |
2004–2006 | 1.06 (1.01–1.12) | 0.013 |
2007–2009 | 1.28 (1.21–1.35) | <0.001 |
2010–2011 | 1.33 (1.25–1.41) | <0.001 |
Type of Endometrial Cancer | ||
Type I | 1.08 (1.03–1.13) | 0.002 |
Type II | Reference |